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Background. A key neuropsychological proposal in schizophrenia is that negative and disorganization symptoms
are associated with diﬀerent patterns of impairment on executive tasks.
Method. Studies reporting correlations between positive, negative or disorganization symptoms and any type of
executive test were meta-analysed. The inﬂuence of moderating factors was also examined, including age, treatment
and stage of illness and whether symptoms were relapsing or persistent. The magnitudes of the correlations were
compared with those for general intellectual impairment.
Results. Pooled correlations between executive impairment and both negative symptoms and disorganization were
signiﬁcant in the small-to-moderate range. That for positive symptoms (‘ reality distortion ’), however, was close to
zero. The pattern of correlations among diﬀerent executive tests diﬀered signiﬁcantly for negative symptoms and
disorganization. Patients with stable clinical pictures showed signiﬁcantly higher correlations with executive
impairment than those with relapsing and remitting illnesses. Both negative symptoms and disorganization also
correlated signiﬁcantly with general intellectual function as indexed by current IQ.
Conclusions. Meta-analysis supports the view that negative symptoms and disorganization are associated with
partially dissociable patterns of executive impairment. However, co-existent general intellectual impairment has been
an important confounding factor in the studies to date.
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Introduction
Based on functional imaging studies (e.g. Heinz et al.
2004 ; Hill et al. 2004) and to some extent on neuro-
pathological ﬁndings (e.g. Harrison & Lewis, 2003),
the frontal lobes are widely believed to be a key area of
brain dysfunction in schizophrenia. Almost as wide-
spread is the belief that they are responsible for some
of the symptoms of the disorder. Thus, authors such as
Liddle (1987a) and Weinberger (1988) have proposed
that the negative symptoms of schizophrenia are
essentially the same phenomenon as the apathy and
emotional indiﬀerence seen in the frontal lobe syn-
drome. Liddle (1987a) and others (e.g. McGrath, 1991 ;
Chaika, 1996) have also proposed that an executive-
type dysfunction aﬀecting speech might give rise to
formal thought disorder, for example by causing poor
planning of discourse and/or an inability to inhibit
inappropriate verbal responses. Similar concepts run
through the most fully articulated theory of schizo-
phrenic symptoms to date, Frith’s (1992) integrative
cognitive neuropsychological account. He also argues
that certain positive symptoms such as passivity and
auditory hallucinations could reﬂect a specialized
form of frontal/executive impairment, the inability to
monitor willed intentions.
Although there are several potential ways of testing
the ‘ frontal lobe’ hypothesis of schizophrenic symp-
toms, investigation has mainly taken place at the
neuropsychological level. Such studies have examined
the correlations between scores on diﬀerent classes of
schizophrenic symptoms and impairment on one or
more measures of executive function. Typically, they
ﬁnd signiﬁcant correlations with negative symptoms
and disorganization, but not with ‘reality distortion’,
that is delusions and hallucinations (for reviews see
Liddle, 2001 ; Donohoe & Robertson, 2003 ; McKenna &
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Oh, 2005). However, a number of studies, some with
large sample sizes, have either had negative ﬁndings
(e.g. Joyce et al. 2002) or have found signiﬁcant corre-
lations with only a minority of the executive tests used
(e.g. Mohamed et al. 1999 ; O’Leary et al. 2000). Another
problem is that these studies commonly also ﬁnd
associations between negative symptoms and/or dis-
organization and impairment on non-executive tests
(see McKenna & Oh, 2005).
Drawing on a distinction between ‘apathetic ’ and
‘disinhibited’ clinical pictures seen in neurological
patients with the frontal lobe syndrome, Liddle
(1987a, 2001) has further proposed that negative and
disorganization symptoms are not just associated with
executive impairment but that they show diﬀerent
patterns of associations with diﬀerent executive tests.
According to Liddle, negative symptoms should
be particularly associated with diﬃculty on tasks
that require the generation of responses, for example
verbal ﬂuency, whereas disorganization should be as-
sociated with impairment on tasks such as the Stroop
test, where prepotent responses have to be inhibited.
Liddle & Morris (1991) found some support for these
distinct patterns of correlation, but the dissociation
was not complete. Considerable overlap in the pattern
of associations of negative and disorganization symp-
toms with diﬀerent executive tests was also found
by Donohoe & Robertson (2003) and McKenna & Oh
(2005) in their reviews.
Existing reviews of clinical–neuropsychological
correlations have mostly been of the narrative or ‘vote
counting’ variety (e.g. Liddle, 2001; Donohue &
Robertson, 2003 ; McKenna & Oh, 2005). One meta-
analysis has been carried out (Nieuwenstein et al.
2001), but this only pooled data from studies using a
single executive test, the Wisconsin Card Sorting
Test (WCST). The aim of this systematic review was
therefore to provide a comprehensive examination
of the relationship between executive impairment
and schizophrenic symptoms using meta-analytic
techniques.
Method
Papers reporting neuropsychological data in relation to
schizophrenic symptoms were searched electronically.
The earliest dates used were the defaults for Medline
(1980), PsycINFO (1985) and EMBASE (1980), and the
search was carried out up to March 2008. Studies were
identiﬁed using the key words ‘schizophrenia ’ and
related terms, ‘negative symptoms’, ‘positive symp-
toms’, ‘poverty syndrome’, ‘disorganization’, ‘de-
lusions’, ‘hallucinations ’, ‘ formal thought disorder ’,
and ‘deﬁcit schizophrenia ’. These were combined
with ‘ frontal lobe’, ‘executive function’, ‘ frontal
cortex’, ‘neuropsychological tests ’, ‘cognition’, ‘work-
ing memory’ and ‘memory short-term’. We also en-
tered the acronyms for symptom scales such as SANS,
SAPS, BPRS and PANSS, and the names of com-
monly used executive tests, such as the Wisconsin
Card Sorting Test, Stroop, verbal ﬂuency, Tower of
London/Hanoi, Trail Making Test, digit span (for
reverse digit span) and the Cognitive Estimates Test.
The electronic search was supplemented by check-
ing book chapters and review articles on the neuro-
psychology of schizophrenia, and the reference lists of
all papers reporting relevant data. Finally, the names
of chief investigators of known ﬁrst-episode studies
of schizophrenia were also searched electronically,
as these studies typically include detailed neuro-
psychological assessments. Both English- and foreign-
language papers were included. Unpublished studies
were not included but publication bias was examined.
The same databases were searched over the same
period for the supplementary meta-analysis of symp-
toms and overall intellectual function, for which
current IQ was used as a measure (see below). Here
the search terms used were IQ, intelligence, intelli-
gence tests, intellect and general intellectual ability.
To be included studies had to report data on adult
patients meeting any diagnostic criteria for schizo-
phrenia. Studies where some of the patients had a
diagnosis of schizo-aﬀective disorder were also in-
cluded. Studies reporting ﬁndings on adolescents or
where the sample consisted only of patients over
65 were excluded. Studies were required to assess
symptoms using a published rating scale [e.g. the Brief
Psychiatric Rating Scale (BPRS), Manchester Scale,
Positive and Negative Syndrome Scale (PANSS),
Positive and Negative and Disorganized Symptoms
Scale (PANADSS), Schedule for Aﬀective Disorders
and Schizophrenia (SADS), Scales for the Assessment
of Positive and Negative Symptoms (SAPS, SANS),
Thought, Language and Communication (TLC) scale
for formal thought disorder, High Royds Evaluation
of Negativity (HEN) and Iager scales for negative
symptoms].
The analysis was based on scores on Liddle’s
three syndromes, hereafter referred to as positive
(‘ reality distortion’, delusions and hallucinations),
negative (‘psychomotor poverty ’) and disorganization
(thought disorder and inappropriate aﬀect with some
authors also including bizarre behaviour). Where in-
dividual classes of symptoms were reported separ-
ately (e.g. delusions and hallucinations or individual
SANS subscale scores for aﬀective ﬂattening, alogia,
anhedonia-asociality, etc.), the relevant correlations
were averaged, providing these permitted a reason-
able approximation to the full range of symptoms in a
particular syndrome.
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Studies that only reported partial symptom data
(e.g. correlations for delusions only or hallucinations
only) were excluded. During the course of the meta-
analysis, however, a relative lack of studies
reporting correlations with disorganization became
apparent, and so it was decided to also include studies
reporting only formal thought disorder. This was
on the grounds that this is arguably the main con-
stituent of disorganization (inappropriate aﬀect is an
uncommon symptom and authors often do not
include bizarre behaviour as part of the syndrome).
Several studies, rather than reporting correlations
for positive, negative and disorganization symptoms,
reported correlations for the older, dichotomous con-
cept of positive and negative symptoms. The concept
of positive symptoms was broader in these studies,
encompassing delusions, hallucinations and formal
thought disorder. Accordingly, it was not possible
to include these studies in the meta-analysis of the
correlates of positive or disorganization symptoms.
However, their data for negative symptoms could
still usually be included. For this reason there were
many more studies in the meta-analysis of negative
symptoms.
The neuropsychological inclusion and exclusion
criteria are summarized in Table 1. Only tests con-
sidered to be executive within the current cognitive
meaning of the term were included. Hence, we
included working memory tasks only if they engaged
the central executive component of Baddeley’s (1986)
model of working memory (i.e. those requiring
manipulation rather than just holding of information
in short-term memory) ; as a result, forward span
tests were not included. Tasks that are known to
activate the prefrontal cortex but do not have any
executive component in the neuropsychological sense
were not included (e.g. long-term memory tasks,
vigilance tasks). Where studies reported composite
measures of executive function, these were only
included if a majority of the contributing tests were
executive according to the above deﬁnition.
We included studies that reported both Pearson and
Spearman correlations. Studies reporting partial cor-
relations were excluded, unless the raw correlations
could be obtained from the authors. Where data were
reported but could not be extracted, the authors were
contacted by email. A small number of studies, rather
than reporting correlations between syndrome scores
and neuropsychological test performance, provided
data on two groups of patients, typically those with
high and low scores on negative symptoms or ‘deﬁcit ’
and ‘non-deﬁcit ’ patients. Such data can be used to
provide a correlation coeﬃcient by calculating the
eﬀect size (d) for the diﬀerence between the high and
low symptom groups, and then converting this to r,
which is mathematically related to d. This procedure
yields a point biserial correlation, which was used in
preference to the also derivable biserial correlation, as
the latter makes assumptions about the normality of
the distribution (see Howell, 1997).
Calculations were performed using D-STAT 1.10
(Johnson, 1993), which uses a ﬁxed-eﬀects model, and
Comprehensive Meta-Analysis v.2 (Borenstein et al.
2006), where the ﬁxed-eﬀects option was again used.
Table 1. Types of executive tests included in the meta-analysis
WCST/other set shifting
WCST (categories achieved and number of
perseverative errors)
Other similar sorting tests (e.g. Category Test)
CANTAB attentional set shifting
Brixton Test
Trail Making Test
Part B
Part B–Part A
Verbal ﬂuency
Category (semantic)
Letter (phonological)
Design ﬂuency
Working memory
Digits backward
Letter-number span
N-back task
CANTAB spatial working memory
Self-ordered pointing
Sentence span
Stroop/other inhibition of prepotent response
Stroop test (error and time measures for the colour-word
interference condition)
Hayling test
Other
Six Elements Test
Cognitive Estimates Test
Tower of London/Hanoi
Dual task performance
Road Map Test
Luria Test
BADS
WCST, Wisconsin Card Sorting Test ; CANTAB,
Cambridge Neuropsychological Test Automated Battery ;
BADS, Behavioural Assessment of the Dysexecutive
Syndrome.
Exclusions : studies reporting only WCST percentage
perseverative errors were not included as this measure can
be criticized (see Laws, 1999). Studies reporting only Trail
Making Test part A time, or time for both parts A and B
together, were also not included. The Continuous
Performance Test and other vigilance tests were also
excluded (see text).
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Homogeneity was examined using the Q statistic and
QB was used to test for signiﬁcant diﬀerences between
mean eﬀect sizes. Various moderating variables were
examined including age, length of illness, treatment
status and type of executive task. Carpenter et al.
(1988) have drawn a distinction between transient
negative symptoms in schizophrenia (i.e. present at
the height of an acute episode) and those that are
enduring (‘deﬁcit ’ symptoms in Carpenter’s term-
inology), with the latter being proposed to have
a greater implication of poor outcome and being
more closely related to underlying neurobiological
mechanisms. In a similar vein, Liddle (1987a) and
Baxter & Liddle (1998) suggested that patients with
persistent symptoms show higher correlations with
neuropsychological test impairment than those who
have relapsing and remitting illnesses. Therefore, we
also examined stability of symptoms as a moderator
variable.
The question of the speciﬁcity of the association
between symptoms and executive impairment was
examined by carrying out a supplementary meta-
analysis of the correlations between positive, negative
and disorganization symptoms and general intellec-
tual impairment. For this purpose current IQ was
chosen, as this was by far the most commonly used
measure in the studies. Included here were studies
reporting Wechsler Adult Intelligence Scale (WAIS)/
WAIS-R/WAIS-III full-scale IQ or verbal or perform-
ance IQ. We did not include studies reporting only
single WAIS subtest scores, but if correlations on three
or more subtest scores were provided these were
averaged to approximate an index of overall IQ. We
also included other current IQ measures including
the Quick Test, Raven’s Matrices, and armed forces
aptitude tests.
Results
Correlations of clinical syndromes with executive
test impairment
Eighty-eight studies were found that included usable
data. These used a range of diﬀerent executive tests.
The purpose of this initial analysis was to establish
the correlations between positive, negative and dis-
organization syndromes and a broad index of execu-
tive impairment. Therefore, studies reporting any
measure of executive function were included in the
analysis. Where a study reported multiple correlations
with diﬀerent executive test scores, these were aver-
aged to provide a composite correlation.
Eighty-one papers reporting 83 studies included
data on the executive correlates of negative symptoms.
The pooled r for these studies was x0.21 [95% conﬁ-
dence interval (CI)x0.24 tox0.18]. The studies were
signiﬁcantly heterogeneous [Q(82)=321.84, p<0.0001].
Homogeneity was achieved by excluding 21 studies ;
this left the pooled eﬀect size similar at x0.20 (CI
x0.23 tox0.17).
The eﬀect size for 40 studies examining the cor-
relates of disorganization was x0.17 (CI x0.21 to
x0.13). These data were heterogeneous [Q(39)=
148.14, p<0.0001]. Homogeneity was achieved by ex-
cluding eight studies, and this increased the pooled
r tox0.28 (CIx0.33 tox0.23).
At +0.01 (CI x0.04 to +0.05), however, the
pooled r for 34 studies of positive symptoms was
negligible. These studies were again heterogeneous
[Q(33)=110.43, p<0.0001], but removing four out-
lying studies had little eﬀect on the pooled r (+0.02,
CIx0.03 to+0.07).
Funnel plots of the correlations for negative symp-
toms and disorganization are shown in Fig. 1. It can
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Fig. 1. Funnel plots of the correlations between executive test scores and negative symptoms and disorganization.
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be seen that the correlations for negative symptoms
were fairly evenly distributed around both sides of
the overall eﬀect size (with a small number of studies
ﬁnding better performance with higher negative
symptom scores). However, for disorganization there
was an obvious absence of studies with small sample
sizes that failed to ﬁnd signiﬁcant correlations, sug-
gesting publication bias.
Moderating factors
Age did not moderate the clinical–neuropsychological
correlations for negative symptoms (n=80 studies,
Z=0.37, p=0.71) and was marginally signiﬁcant for
disorganization (n=40 studies, Z=x1.96, p=0.05)
(correlations were higher in older patients). Duration
of illness did not signiﬁcantly moderate the size of the
correlation between negative symptoms and executive
impairment (n=72 studies, Z=x1.08, p=0.28), but
it did for disorganization (n=36 studies, Z=x3.39,
p=0.0006) ; correlations were higher in studies on
patients with longer duration of illness.
Treatment moderated the pooled correlation for
negative symptoms [r for 58 studies on treated
patients=x0.19 v.x0.29 for seven studies on un-
treated patients, QB(1)=6.28, p=0.01]. This was also
true for disorganization [r for 27 studies on treated
patients=x0.22 v.x0.14 for ﬁve studies on untreated
patients, QB(1)=4.09, p=0.04]. However, it should be
noted that in both analyses the number of studies
carried out on untreated patients was small.
As mentioned earlier, Liddle (1987a) and Baxter &
Liddle (1998) have suggested that correlations be-
tween negative symptoms and neuropsychological
test impairment may be more marked in patients with
persistent symptoms than in those who have relapsing
and remitting illnesses. To examine this issue, we di-
chotomized studies into those carried out on patients
with ‘acute/remitting ’ symptoms and those on
patients with ‘stable/persistent ’ symptoms. Patients
in the former category were described in terms
such as ‘acute ’, ‘acutely ill ’ or ‘ relapsed’ ; studies on
in-patients described as stabilized or just prior to
discharge were excluded. Studies in the latter category
were carried out on out-patients, or on chronically
hospitalized patients, if it was also speciﬁed that they
were in a clinically stable condition. This distinction
signiﬁcantly moderated the correlations with negative
symptoms [r for 19 studies on acute/remitting
patients=x0.13 v.x0.24 for 35 studies carried out on
stable/persistent patients, QB(1)=20.93, p<0.0001].
It also signiﬁcantly moderated the correlations with
disorganization [r for 11 studies on acutely relapsed
patients=x0.12 v.x0.28 for 16 studies carried out on
stable patients, QB(1)=18.46, p<0.0001]. The ﬁndings
are illustrated in Fig. 2.
Correlations with diﬀerent executive tests
The correlations between negative symptoms and
disorganization and the ﬁve main categories of
executive tests identiﬁed in Table 1 are shown in
Table 2. For both negative symptoms and disorgani-
zation there was signiﬁcant heterogeneity among
the correlations [negative symptoms: QB(4)=42.27 ;
disorganization : QB(4)=33.71, both p<0.001], indica-
ting that there was signiﬁcant variation among the
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Fig. 2. Pooled correlations between negative symptoms and
executive impairment and disorganization and executive
impairment in studies carried out on patients with ‘acute/
remitting ’ (%) and ‘stable/persistent ’ (&) symptoms.
Table 2. Signiﬁcant pooled correlations between negative and disorganization syndromes and diﬀerent executive tests
r (95% CI)
negative symptoms
No. of
studies
r (95% CI)
disorganization
No. of
studies
WCST, set shifting x0.16 (x0.20 tox0.13) 43 x0.19 (x0.24 tox0.14) 19
Trails B x0.24 (x0.29 tox0.18) 24 x0.31 (x0.40 tox0.22) 10
Verbal ﬂuency x0.27 (x0.31 tox0.23) 40 x0.11 (x0.17 tox0.05) 18
Working memory x0.14 (x0.22 tox0.07) 13 x0.12 (x0.23 tox0.00) 6
Stroop/Hayling x0.13 (x0.21 tox0.05) 16 x0.29 (x0.38 tox0.21) 10
CI, Conﬁdence interval ; WCST, Wisconsin Card Sorting Test.
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correlations with the ﬁve types of tests. For negative
symptoms the correlations ranged from x0.27 on
verbal ﬂuency and x0.24 on the Trail Making Test,
part B down tox0.14 on working memory andx0.13
on the Stroop test. For disorganization the range was
similar, from x0.31 on the Trail Making Test, part B
down to x0.12 on working memory and x0.11 on
verbal ﬂuency.
It can be seen from Table 2 that verbal ﬂuency
impairment was nearly three times more strongly
associated with negative symptoms than with dis-
organization (x0.27 v. x0.11). This diﬀerence was
signiﬁcant [QB(1)=40.44, p<0.0001]. Impairment on
the Stroop Test, by contrast, was twice as highly cor-
related with disorganization as it was with negative
symptoms (x0.29 v.x0.13), with the diﬀerence again
being signiﬁcant [QB(1)=8.29, p=0.004].
Correlations between clinical syndromes and IQ
The pooled correlation between IQ and negative
symptoms in 30 studies was x0.21 (CI x0.26 to
x0.17), rising to x0.23 (CI x0.28 to x0.17) after six
outliers were removed. The pooled correlation be-
tween IQ and disorganization wasx0.21 (CIx0.28 to
x0.14). This increased to x0.28 (CI x0.35 to x0.19)
after excluding two outlying studies.
Discussion
This meta-analysis found that negative schizophrenic
symptoms and disorganization, but not positive
symptoms, are signiﬁcantly associated with impair-
ment on executive tests. Insofar as executive tests
index frontal lobe function, meta-analysis therefore
provides support for the view that frontal dysfunction
underlies these two classes of symptoms. At the same
time, atx0.20 andx0.28 (homogenized) respectively,
the correlations were modest, falling between the
‘rule-of-thumb’ values of ‘small ’ (0.1) and ‘medium’
(0.3). These values are broadly in keeping with those
of an earlier meta-analysis by Nieuwenstein et al.
(2001), who found a pooled correlation of x0.27 with
negative symptoms in 15 studies and of x0.25 with
disorganization in six studies using the WCST,
but no signiﬁcant correlation with positive symptoms
(pooled r of x0.04) in four studies. As Nieuwenstein
et al. (2001) pointed out, this means that symptom
dimensions account for less than 10% of the variance
in performance on executive tests in schizophrenia,
and suggests that any relationship between symptoms
and underlying pathophysiological abnormality is
relatively remote. Further caution is necessary in
interpreting the relationship between disorganization
and executive impairment, where we found that there
was evidence of publication bias.
Nevertheless, signiﬁcant moderating factors were
identiﬁed in our meta-analysis, indicating that the as-
sociations may be stronger in some types of patient.
High correlations between executive impairment and
negative symptoms and/or disorganization have been
a feature of several studies carried out on chronically
hospitalized patients (e.g. Liddle & Morris, 1991 ;
Brown & White, 1992), whereas correlations have
sometimes been low or negligible in studies of ﬁrst-
episode patients (e.g. Mohamed et al. 1999 ; Joyce et al.
2002 ; Rund et al. 2004). However, there are numerous
exceptions to this rule and our meta-analysis did not
ﬁnd robust evidence that duration of illness was a
moderating factor : it was signiﬁcant for disorganiz-
ation but not for negative symptoms.When the studies
were divided according to a somewhat related dis-
tinction, into those carried out on patients with
relapsing and remitting symptoms versus those with
stable, persistent symptoms, a clearer moderating
eﬀect emerged that applied to both negative symp-
toms and disorganization. It seems that schizophrenic
patients with established, relatively unchanging
clinical pictures – one deﬁnition of chronicity – show
stronger associations between symptoms and neuro-
psychological deﬁcits than those whose symptoms
come and go in acute attacks.
Why this should be so is not known. However, it is a
theme that has surfaced before in the literature. Over
50 years ago, Kleist (Fish, 1957 ; Kleist, 1960) argued
that the initially somewhat amorphous presentations
of schizophrenia crystallized into a large number of
stable states as the disorder evolved, each of which
was dominated by one or a few symptoms that
reﬂected dysfunction in a particular brain area. For
Kleist, the end states of ‘drive poor catatonia ’ (roughly
equivalent to negative symptom schizophrenia)
and hebephrenia were psychiatric analogues of the
apathetic and disinhibited forms of the frontal lobe
syndrome respectively. More recently, Carpenter and
co-workers (Carpenter et al. 1988 ; Kirkpatrick et al.
2001) have argued that pathophysiological correlates
of negative symptoms are most evident in patients
who have enduring symptoms of this type, and
have elevated this into the principle of a conceptual
separation of deﬁcit and non-deﬁcit forms of schizo-
phrenia. Liddle and co-workers (Liddle, 1987a) ;
Liddle et al. 1992; Baxter & Liddle, 1998) have also
argued that diﬀerent pathological processes might
underlie symptoms, particularly negative symptoms,
in chronic and remitting illnesses.
The other main moderating factor identiﬁed in
this meta-analysis was neuroleptic treatment, where
we found higher correlations in treated patients.
However, the fact that there were few studies on
untreated patients (7/83 in the case of negative
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symptoms and 5/40 in the case of disorganization)
suggests this ﬁnding should be interpreted with
caution.
A supplementary meta-analysis revealed that
both negative symptoms and disorganization showed
similar levels of correlation with IQ as with executive
impairment. This raises questions about the speciﬁcity
of the relationship between symptoms and executive
impairment. General intellectual impairment is preva-
lent in schizophrenia and will in itself give rise to poor
performance on executive tests without implying the
presence of a speciﬁc neuropsychological deﬁcit (see
Goldberg et al. 2001 for a review). The same reasoning
suggests that, when correlations are found between
symptoms and executive impairment, this could also
reﬂect correlations with coexistent general intellectual
impairment. Of course, IQ is far from perfect as a
measure of general intellectual impairment, as it varies
widely across normal individuals. Nor is IQ ideal as a
non-executive control measure ; executive function is
variably but overall moderately highly correlated with
IQ in normal subjects (e.g. Obonswain et al. 2002),
and frontal lobe lesions tends to lower IQ, at least as
measured on ‘ﬂuid’ as opposed to ‘crystallized’ tests
(Duncan et al. 1995). An extreme view is that executive
function and (ﬂuid) IQ are one and the same thing
(Duncan, 1995). Given these complexities, as well as
the relatively small number of studies we were able to
ﬁnd that included measures of IQ, our ﬁndings should
probably not be regarded as discrediting the associa-
tion between negative symptoms/disorganization and
executive impairment, but they clearly indicate that
general intellectual function ought to be taken into
consideration in future studies.
The ﬁndings of this meta-analysis support the view
that the correlation between executive impairment
and schizophrenic symptoms is speciﬁc in another
sense, that of showing distinct patterns of association
with diﬀerent executive tests. Thus, negative symp-
toms were associated with verbal ﬂuency but con-
siderably less so with the Stroop test, whereas
disorganization showed the reverse pattern. These
diﬀerences accord well with Liddle’s (1987a, 2001 ;
Liddle & Morris, 1991) proposal that the psychomotor
poverty syndrome is a form of frontal lobe apathy,
leading to slowness and failure to generate actions,
whereas the disorganization syndrome reﬂects a
frontal disinhibition syndrome characterized chieﬂy
by failure to inhibit prepotent responses. At the same
time, both negative symptoms and disorganization
showed signiﬁcant correlations with the Trail Making
Test, part B (r=x0.24 andx0.31) and with the WCST
(x0.16 and x0.20). It might be possible to explain
these failures of dissociation, however. Thus, the
WCST is sensitive to both frontal and non-frontal
lesions (e.g. Lezak et al. 2004) and so successful
performance might be considered to require a range
of diﬀerent executive (and non-executive) cognitive
process. Similarly, impairment on the Trail Making
Test, part B can obviously be due to failure to
inhibit prepotent responses, but performance on this
test should also be sensitive to the occurrence of
perseveration.
An aside to these ﬁndings is that the correlations
between working memory impairment and both
negative symptoms (x0.14) and disorganization
(x0.12) fell into the ‘small ’ range, and were among
lowest levels of association seen in the study. In recent
years working memory impairment has been regarded
as a key explanatory neuropsychological construct in
schizophrenia (e.g. Goldman-Rakic & Selemon, 1997 ;
Silver et al. 2003). Whatever merits this proposal has,
our meta-analysis suggests that it has little role in ex-
plaining the symptoms of the disorder. This is despite
the fact that we were scrupulous about including only
tests that tapped the central executive component
of working memory and not just Baddeley’s (1986)
two slave systems, the articulatory loop and the
visuospatial sketch pad.
Neuropsychology is not the only way to investigate
the ‘ frontal lobe’ hypothesis of schizophrenic symp-
toms. Nevertheless, the other evidence, which derives
essentially from functional imaging studies, is sur-
prisingly limited. In the ﬁrst study using modern
voxel-based techniques, Liddle et al. (1992) found
that negative symptoms were associated with under-
activity in wide areas of the prefrontal cortex bi-
laterally, and that disorganization was signiﬁcantly
associated with underactivity in Broca’s area on the
left and its analogue in the right frontal lobe cortex
(and also hyperactivity in the right anterior cingulate
cortex). However, further studies have been approxi-
mately equally divided between those supporting and
those failing to support the association with prefrontal
abnormality (for a review, see McKenna, 2007). The
even smaller number of functional imaging studies of
formal thought disorder (e.g. McGuire et al. 1998 ;
Kircher et al. 2001, 2002 ; Weinstein et al. 2006) tends to
implicate the temporal lobes more than the frontal
lobes. It thus seems that, although neuropsychological
studies may have demonstrated a link between certain
classes of schizophrenic symptoms and the dys-
executive syndrome, the related question of whether
negative symptoms and disorganization are analogues
of the apathetic and disinhibited forms of the frontal
lobe syndrome remains unanswered.
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